Cargando…
Novel radiomic analysis on bi-parametric MRI for characterizing differences between MR non-visible and visible clinically significant prostate cancer
BACKGROUND: around one third of clinically significant prostate cancer (CsPCa) foci are reported to be MRI non-visible (MRI─). OBJECTIVE: To quantify the differences between MR visible (MRI+) and MRI(─) CsPCa using intra- and peri-lesional radiomic features on bi-parametric MRI (bpMRI). METHODS: Thi...
Autores principales: | Li, Lin, Shiradkar, Rakesh, Tirumani, Sree Harsha, Bittencourt, Leonardo Kayat, Fu, Pingfu, Mahran, Amr, Buzzy, Christina, Stricker, Phillip D., Rastinehad, Ardeshir R., Magi-Galluzzi, Cristina, Ponsky, Lee, Klein, Eric, Purysko, Andrei S., Madabhushi, Anant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311200/ https://www.ncbi.nlm.nih.gov/pubmed/37396490 http://dx.doi.org/10.1016/j.ejro.2023.100496 |
Ejemplares similares
-
An integrated nomogram combining deep learning, Prostate Imaging–Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study
por: Hiremath, Amogh, et al.
Publicado: (2021) -
Combination of Peri-Tumoral and Intra-Tumoral Radiomic Features on Bi-Parametric MRI Accurately Stratifies Prostate Cancer Risk: A Multi-Site Study
por: Algohary, Ahmad, et al.
Publicado: (2020) -
Prostate Surface Distension and Tumor Texture Descriptors From Pre-Treatment MRI Are Associated With Biochemical Recurrence Following Radical Prostatectomy: Preliminary Findings
por: Shiradkar, Rakesh, et al.
Publicado: (2022) -
A novel imaging based Nomogram for predicting post-surgical biochemical recurrence and adverse pathology of prostate cancer from pre-operative bi-parametric MRI
por: Li, Lin, et al.
Publicado: (2020) -
Delta radiomic patterns on serial bi-parametric MRI are associated with pathologic upgrading in prostate cancer patients on active surveillance: preliminary findings
por: Midya, Abhishek, et al.
Publicado: (2023)